HUP9901579A2 - A humán béta-2 integrin alfa-alegysége - Google Patents
A humán béta-2 integrin alfa-alegységeInfo
- Publication number
- HUP9901579A2 HUP9901579A2 HU9901579A HUP9901579A HUP9901579A2 HU P9901579 A2 HUP9901579 A2 HU P9901579A2 HU 9901579 A HU9901579 A HU 9901579A HU P9901579 A HUP9901579 A HU P9901579A HU P9901579 A2 HUP9901579 A2 HU P9901579A2
- Authority
- HU
- Hungary
- Prior art keywords
- alpha subunit
- human beta
- integrin alpha
- discloses
- fragments
- Prior art date
Links
- 101001033280 Homo sapiens Cytokine receptor common subunit beta Proteins 0.000 title 1
- 102000055647 human CSF2RB Human genes 0.000 title 1
- 108010044426 integrins Proteins 0.000 title 1
- 102000006495 integrins Human genes 0.000 title 1
- 239000012634 fragment Substances 0.000 abstract 2
- 108010059108 CD18 Antigens Proteins 0.000 abstract 1
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 230000009870 specific binding Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70546—Integrin superfamily
- C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
- C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6818—Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
A találmány közzéteszi az ad-nek nevezett új hűmán b2 integrin a-alegységét, és az ezt előállító eljárásőkat és anyagőkat. Ezenkívülközzétesz fúziós fehérjéket is, amelyek tartalmazzák azextracellűláris ad fehérje fragmenseket, az ad I dőmain fragmenseketvagy a teljes hősszúságú ad pőlipeptideket és a hűmán imműnőglőbűlinkőnstans régióit. Az ad-re specifikűs kötőmőlekűlákat is közzéteszi atalálmány, mivel ezek hasznősak más fajőkból izőlált ad DNS biőlógiaiaktivitásának mérséklésére, melyek egyben a hűmán ad-t kódőlószekvenciákkal hőmőlógiát műtatnak. ŕ
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/605,672 US5817515A (en) | 1993-12-23 | 1996-02-22 | Human B2 integrin alpha subunit antibodies |
PCT/US1997/002713 WO1997031099A1 (en) | 1996-02-22 | 1997-02-24 | Human beta 2 integrin alpha subunit |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP9901579A2 true HUP9901579A2 (hu) | 1999-08-30 |
HUP9901579A3 HUP9901579A3 (en) | 2001-10-29 |
HU223977B1 HU223977B1 (hu) | 2005-03-29 |
Family
ID=24424704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9901579A HU223977B1 (hu) | 1996-02-22 | 1997-02-24 | Alfa-d-integrin-re specifikus antitestek |
Country Status (18)
Country | Link |
---|---|
US (1) | US5817515A (hu) |
EP (1) | EP0835301B1 (hu) |
JP (1) | JP2001526524A (hu) |
CN (1) | CN1103812C (hu) |
AT (1) | ATE293685T1 (hu) |
AU (1) | AU723110B2 (hu) |
BR (1) | BR9702101A (hu) |
CA (1) | CA2218755C (hu) |
CZ (1) | CZ287921B6 (hu) |
DE (1) | DE69733051D1 (hu) |
FI (1) | FI974018A (hu) |
HU (1) | HU223977B1 (hu) |
IL (1) | IL122011A (hu) |
NO (1) | NO318764B1 (hu) |
PL (1) | PL187013B1 (hu) |
RU (1) | RU2183671C2 (hu) |
SK (1) | SK283135B6 (hu) |
WO (1) | WO1997031099A1 (hu) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5837478A (en) * | 1993-12-23 | 1998-11-17 | Icos Corporation | Method of identifying modulators of binding between and VCAM-1 |
US6620915B2 (en) * | 1993-12-23 | 2003-09-16 | Icos Corporation | Monoclonal antibodies specific for integrin α-d subunit |
US20030055231A1 (en) * | 1998-10-28 | 2003-03-20 | Jian Ni | 12 human secreted proteins |
JP2003527439A (ja) | 2000-03-17 | 2003-09-16 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | 抗cd18抗体と抗ccr2抗体の混合物を用いる狭窄および再狭窄を抑制する方法 |
WO2023235971A1 (en) * | 2022-06-08 | 2023-12-14 | The Regents Of The University Of California | Antibodies and immunotherapies that target the active conformation of integrin beta 2 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4271139A (en) * | 1978-03-27 | 1981-06-02 | Hiram Hart | Scintillation proximity assay |
US4568649A (en) * | 1983-02-22 | 1986-02-04 | Immunex Corporation | Immediate ligand detection assay |
WO1992006697A1 (en) * | 1990-10-23 | 1992-04-30 | Repligen Corporation | Anti-inflammatory composition |
CA2120500A1 (en) * | 1991-10-01 | 1993-04-15 | Mitsuaki Isobe | Preventing allograft rejection with antibodies to adhesion molecules |
DE69229275T2 (de) * | 1991-10-04 | 1999-12-30 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Rockville | Herstellung eines arzneimittels zur behandlung von augenentzündung durch blockierung von zelladhäsionsmolekulen |
US5470953A (en) * | 1993-12-23 | 1995-11-28 | Icos Corporation | Human β2 integrin α subunit |
WO1995027736A1 (en) * | 1994-04-12 | 1995-10-19 | Boehringer Ingelheim Pharmaceuticals, Inc. | Use of agents which block intercellular adhesion molecule/receptor interaction in the treatment of respiratory viral infection |
-
1996
- 1996-02-22 US US08/605,672 patent/US5817515A/en not_active Expired - Fee Related
-
1997
- 1997-02-24 RU RU97119175/13A patent/RU2183671C2/ru not_active IP Right Cessation
- 1997-02-24 JP JP53033797A patent/JP2001526524A/ja active Pending
- 1997-02-24 PL PL97323195A patent/PL187013B1/pl not_active IP Right Cessation
- 1997-02-24 CA CA002218755A patent/CA2218755C/en not_active Expired - Fee Related
- 1997-02-24 AU AU21333/97A patent/AU723110B2/en not_active Ceased
- 1997-02-24 SK SK1409-97A patent/SK283135B6/sk unknown
- 1997-02-24 AT AT97906713T patent/ATE293685T1/de not_active IP Right Cessation
- 1997-02-24 DE DE69733051T patent/DE69733051D1/de not_active Expired - Lifetime
- 1997-02-24 CN CN97190406A patent/CN1103812C/zh not_active Expired - Fee Related
- 1997-02-24 BR BR9702101A patent/BR9702101A/pt not_active IP Right Cessation
- 1997-02-24 CZ CZ19973286A patent/CZ287921B6/cs not_active IP Right Cessation
- 1997-02-24 WO PCT/US1997/002713 patent/WO1997031099A1/en active IP Right Grant
- 1997-02-24 IL IL12201197A patent/IL122011A/en not_active IP Right Cessation
- 1997-02-24 EP EP97906713A patent/EP0835301B1/en not_active Expired - Lifetime
- 1997-02-24 HU HU9901579A patent/HU223977B1/hu not_active IP Right Cessation
- 1997-10-21 FI FI974018A patent/FI974018A/fi unknown
- 1997-10-21 NO NO19974852A patent/NO318764B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
SK283135B6 (sk) | 2003-03-04 |
CA2218755A1 (en) | 1997-08-28 |
EP0835301A1 (en) | 1998-04-15 |
BR9702101A (pt) | 1999-07-20 |
IL122011A0 (en) | 1998-03-10 |
FI974018A (fi) | 1997-12-03 |
HUP9901579A3 (en) | 2001-10-29 |
AU2133397A (en) | 1997-09-10 |
PL187013B1 (pl) | 2004-04-30 |
US5817515A (en) | 1998-10-06 |
HU223977B1 (hu) | 2005-03-29 |
SK140997A3 (en) | 1998-09-09 |
NO974852L (no) | 1997-12-19 |
CN1189851A (zh) | 1998-08-05 |
CA2218755C (en) | 1999-08-31 |
CZ328697A3 (cs) | 1998-07-15 |
DE69733051D1 (de) | 2005-05-25 |
NO318764B1 (no) | 2005-05-02 |
RU2183671C2 (ru) | 2002-06-20 |
NO974852D0 (no) | 1997-10-21 |
CZ287921B6 (cs) | 2001-03-14 |
WO1997031099A1 (en) | 1997-08-28 |
PL323195A1 (en) | 1998-03-16 |
IL122011A (en) | 2001-05-20 |
CN1103812C (zh) | 2003-03-26 |
FI974018A0 (fi) | 1997-10-21 |
ATE293685T1 (de) | 2005-05-15 |
JP2001526524A (ja) | 2001-12-18 |
AU723110B2 (en) | 2000-08-17 |
EP0835301B1 (en) | 2005-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69533564D1 (de) | Effektor-Proteine für Rapamycin | |
EP1067182A3 (en) | Secretory protein or membrane protein | |
ATE529509T1 (de) | Selektion von proteinen unter verwendung von rna- protein-fusionen | |
DK1005540T3 (da) | IKK-beta-proteiner, nukleinsyrer og fremgangsmåder | |
NO962991L (no) | Zink-finger-proteinderivater og fremgangsmåter derav | |
DK0686161T3 (da) | Alfa-underenhed af humane beta2-integriner | |
ATE516348T1 (de) | Glykoprotein vi und dessen anwendungen | |
DK0528932T3 (da) | Protein associeret med akut pancreatitis og midler til diagnose af akut pancreatitis | |
DK1015575T3 (da) | Shuffling af heterologe DNA-sekvenser | |
DE69839444D1 (de) | Smad 6 und dessen anwendungen | |
ATE380867T1 (de) | Lactoferrinrezeptorgen von moraxella | |
ATE304052T1 (de) | Humane checkpointkinase, hcds1, zusammensetzungen und verfahren | |
HUP9901579A2 (hu) | A humán béta-2 integrin alfa-alegysége | |
EP0992584A3 (en) | Purified mammalian FLT3 ligands and agonists and antagonists thereof | |
ATE335091T1 (de) | Bc200 rna, daraus abgeleitete proben und entsprechende anwendungen | |
BR9914090A (pt) | ácidos nucléicos codificando uma sub-unidade gama da proteìna g envolvida em transdução sensorial | |
WO2003012102A3 (fr) | Acides nucleiques codant des proteines a domaine hect | |
MX9708107A (es) | Subunidad alfa de integrina beta 2 humana. | |
WO2001083747A3 (fr) | Proteines a prions et leurs utilisations | |
DE60045556D1 (de) | Rekombinante proteine zur verwendung als endotoxinbiosensor, als antimikrobielle und antiendotoxin therapeutika und für die entfernung von endotoxin | |
WO2000065055A8 (en) | Human transporter proteins | |
WO2003044160A3 (en) | Novel molecules of the card related protein family and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HFG4 | Patent granted, date of granting |
Effective date: 20050218 |
|
MM4A | Lapse of definitive patent protection due to non-payment of fees |